• Home
  • Reagents
    • Overview
    • Primary Antibodies
      • Overview
      • Anti-Allergen Antibodies
      • Anti-Coronavirus Antibodies
      • Anti-Virus Antibodies
      • Antibodies to Epitope Tags
      • Bispecific Antibody Reagents
      • DNA/RNA Research Antibodies
      • Recombinant Isotype Controls
      • Tumor Marker Antigens
      • Recombinant Antibodies from Human Patients
      • Immunotherapy Research Antibodies
      • Research-Grade Biosimilars
      • VivopureX™ Antibodies for In Vivo Research
    • Secondary Antibodies
      • Anti-Human Immunoglobulin Antibodies
      • Anti-Non-Human Primate (NHP) Immunoglobulin Antibodies
      • Other Secondary Antibodies
    • Recombinant Proteins
      • Overview
      • Veterinary IgE Fc Proteins
      • Fc Fusion Proteins
      • Immunoglobulin Fc domains (Ig Fc domains)
      • Multi-Tag Control Proteins
      • Recombinant Free Light Chains
  • Services
    • Overview
    • Antibody Engineering
      • Overview
      • Antibody Humanization Service
      • Bispecific and Trispecific Antibodies
    • Antibody Sequencing
      • Overview
      • Hybridoma Sequencing
      • Antibody Protein Sequencing
      • Polyclonal Antibody Sequencing
    • Antibody Expression
      • Overview
      • HEXpress™ HEK Antibody Production
      • CHXpress™ CHO Antibody Production
      • FleXpress™ High-Throughput Antibody Production
  • Our Technology
    • Why go recombinant?
    • Our Recombinant Technology
    • Our Customers
      • Pharma/Biotech
      • Diagnostic Developers
      • Academic Researchers
    • Formats We Have Made
      • Non-IgG Isotypes
      • Chimeric Antibodies
      • Antibody Fragments
      • Fc Silent™ Antibodies
      • Periodic Table of Antibodies
    • License Your Antibodies
    • Animal-Free Antibodies
  • About Us
    • Overview
    • Our Management Team
    • Our Sister Company
    • Testimonials & Case Studies
    • ISO Certification
    • Careers
    • Contact Us
  • Antibody Resource
    • Overview
    • Antibody Overview
    • Antibody Engineering
    • External Resources
  • News & Events
    • Events
    • Blog
    • In the News
    • Newsletter
    • Publications
    • Company Resources
  • How to Order
    • Direct Order
    • Distributors
  • Contact us
  • FAQs
£0.00
0 items
  • Contact us
  • FAQs
United Kingdom (UK)
  • United States (US)
  • United Kingdom (UK)
  • Germany
  • Canada
  • Austria
  • Belgium
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Gibraltar
  • Greece
  • Hong Kong
  • Hungary
  • Iceland
  • Ireland
  • Israel
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Monaco
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • South Korea
  • Spain
  • Sweden
  • Switzerland
  • Other countries
£0.00
0 items
Menu
  • Home
  • Reagents
    • Overview
    • Primary Antibodies
      • Overview
      • Anti-Allergen Antibodies
      • Anti-Coronavirus Antibodies
      • Anti-Virus Antibodies
      • Antibodies to Epitope Tags
      • Bispecific Antibody Reagents
      • DNA/RNA Research Antibodies
      • Recombinant Isotype Controls
      • Tumor Marker Antigens
      • Recombinant Antibodies from Human Patients
      • Immunotherapy Research Antibodies
      • Research-Grade Biosimilars
      • VivopureX™ Antibodies for In Vivo Research
    • Secondary Antibodies
      • Anti-Human Immunoglobulin Antibodies
      • Anti-Non-Human Primate (NHP) Immunoglobulin Antibodies
      • Other Secondary Antibodies
    • Recombinant Proteins
      • Overview
      • Veterinary IgE Fc Proteins
      • Fc Fusion Proteins
      • Immunoglobulin Fc domains (Ig Fc domains)
      • Multi-Tag Control Proteins
      • Recombinant Free Light Chains
  • Services
    • Overview
    • Antibody Engineering
      • Overview
      • Antibody Humanization Service
      • Bispecific and Trispecific Antibodies
    • Antibody Sequencing
      • Overview
      • Hybridoma Sequencing
      • Antibody Protein Sequencing
      • Polyclonal Antibody Sequencing
    • Antibody Expression
      • Overview
      • HEXpress™ HEK Antibody Production
      • CHXpress™ CHO Antibody Production
      • FleXpress™ High-Throughput Antibody Production
  • Our Technology
    • Why go recombinant?
    • Our Recombinant Technology
    • Our Customers
      • Pharma/Biotech
      • Diagnostic Developers
      • Academic Researchers
    • Formats We Have Made
      • Non-IgG Isotypes
      • Chimeric Antibodies
      • Antibody Fragments
      • Fc Silent™ Antibodies
      • Periodic Table of Antibodies
    • License Your Antibodies
    • Animal-Free Antibodies
  • About Us
    • Overview
    • Our Management Team
    • Our Sister Company
    • Testimonials & Case Studies
    • ISO Certification
    • Careers
    • Contact Us
  • Antibody Resource
    • Overview
    • Antibody Overview
    • Antibody Engineering
    • External Resources
  • News & Events
    • Events
    • Blog
    • In the News
    • Newsletter
    • Publications
    • Company Resources
  • How to Order
    • Direct Order
    • Distributors

Home News & Events

News & Events

Absolute Antibody has grown rapidly since our founding in 2012. Our lab is continually innovating to advance recombinant antibody technology, our reagents catalog of engineered recombinant antibodies is always growing, and our company continues to expand globally. Follow the below links to learn more about what’s new and exciting at Absolute Antibody.

Events

Check out our upcoming conference schedule to see where we’re exhibiting and presenting.
Find out more

Blog

Stay updated on Absolute Antibody news, technologies and products.
Find out more

In the News

View our press releases and other media coverage.
Find out more

Newsletter

Sign up for our quarterly e-newsletter, which covers new developments in engineered antibodies.
Find out more

Publications

We’re always excited to see peer-reviewed publications citing Absolute Antibody products and services.
Find out more

Company Resources

Our latest posters, presentations and brochures available for download.
Find out more
Queen's Award For Enterprise
Subscribe to our e-newsletter
Twitter
LinkedIn

Explore this site

Primary Antibodies
  • Anti-Allergen Antibodies
  • Anti-Coronavirus Antibodies
  • Anti-Virus Antibodies
  • Antibodies to Epitope Tags
  • Bispecific Antibody Reagents
  • DNA/RNA Research Antibodies
  • Recombinant F4/80 Clone CI:A3-1
  • Recombinant Isotype Controls
  • Tumor Marker Antigens
  • Recombinant Antibodies from Human Patients
  • Immunotherapy Research Antibodies
  • Research-Grade Biosimilars
  • VivopureX™ Antibodies for In Vivo Research
  • Other Products
Secondary Antibodies
  • Anti-Human Immunoglobulin Antibodies
  • Anti-Non-Human Primate (NHP) Immunoglobulin Antibodies
  • Other Secondary Antibodies
Recombinant Proteins
  • Veterinary IgE Fc Proteins
  • Fc Fusion Proteins
  • Immunoglobulin Fc domains (Ig Fc domains)
  • Multi-Tag Control Protein
  • Recombinant Free Light Chains

Copyright © 2023 Absolute Antibody. All rights reserved

  • Careers
  • Terms and Conditions
  • Privacy Policy

Website design by Electric Studio - Digital WordPress Agency Oxford